Characterization of two common 5' polymorphisms in <it>PEX1 </it>and correlation to survival in PEX1 peroxisome biogenesis disorder patients
Thoms Sven, Grønborg Sabine, Rabenau Jana and 3 more
BMC Medical Genetics · 2011
doi:10.1186/1471-2350-12-109 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Background</p> <p>Mutations in PEX1 are the most common primary cause of Zellweger syndrome. In addition to exonic mutations, deletions and splice site mutations two 5' polymorphisms at c.-137 and c.-53 with a potential influence on PEX1 protein levels have been described in the 5' untranslated region (UTR) of the <it>PEX1 </it>gene.</p> <p>Methods</p> <p>We used RACE and in silico promoter prediction analysis to study the 5' UTR of <it>PEX1</it>. We determined the distribution of <it>PEX1 </it>5' polymorphisms in a cohort of 30 Zellweger syndrome patients by standard DNA sequencing. 5' polymorphisms were analysed in relation to the two most common mutations in <it>PEX1 </it>and were incorporated into a novel genotype-phenotype analysis by correlation of three classes of <it>PEX1 </it>mutations with patient survival.</p> <p>Results</p> <p>We provide evidence that the polymorphism 137 bp upstream of the ATG codon is not part of the UTR, rendering it a promoter polymorphism. We show that the first, but not the second most common <it>PEX1 </it>mutation arose independently of a specific upstream polymorphic constellation. By genotype-phenotype analysis we identified patients with identical exonic mutation and identical 5' polymorphisms, but strongly differing survival.</p> <p>Conclusions</p> <p>Our study suggests that two different types of <it>PEX1 </it>5' polymorphisms have to be distinguished: a 5' UTR polymorphism at position c.-53 and a promoter polymorphism 137 bp upstream of the PEX1 start codon. Our results indicate that the exonic <it>PEX1 </it>mutation correlates with patient survival, but the two 5' polymorphisms analysed in this study do not have to be considered for diagnostic and/or prognostic purposes.</p>
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.